Codice Viola
@CodiceViolaInformazioni aggiornate sullo stato dell'arte del tumore del pancreas viste attraverso gli occhi dei pazienti Italian Pancreatic Cancer Advocacy Organization
Similar User
@P_C_E_
@AISP_Pancreas
@StefanoCrippa6
@RobValente83
@worldpcc
@nine_degraaf
@Totuccio1983
@martachrvll
@Valsecchifdn
@arghavan_salles
@CancerParcel
@hbpsurg_eu
@spartelli
@albe_balduzzi
@precisionpanc
We have advocated for the same idea on the irinotecan vs Nal-iri for over three years. We are astonished to read somebody talking of a practice-changing protocol.
Read the news that NALIRIFOX got approved today by the FDA. Don’t be misled to believe that this represents any innovation. This is a pseudo innovation for which you get to pay more without any added benefits. We discuss this and other pancreatic cancer treatments in our recent…
The article confirms that NALIRIFOX is not better than FOLFIRINOX against a considerably higher price of NALIRIFOX compared to FOLFIRINOX
Our work is out on @JAMANetworkOpen ❗️ Is NALIRIFOX better than FOLFIRINOX as 1st line for metastatic #pancsm ❓ ❎similar OS and PFS, ⚠️different clinical and 💰 toxicity “I suppose we all thought that one way or another” jamanetwork.com/journals/jaman…
In un mondo che vive di aneddoti c'è un gran bisogno di conoscenza e esperienza in questo ambito in
🎓 Annunciazione annunciazione! La prossima edizione del nostro Master in #Statistica per la #RicercaClinica e #Epidemiologia è in arrivo! 🚀 Diffondi la voce ed entra in contatto con noi! 🌐 Resta aggiornato per il bando ufficiale. #Master2023 #FormazioneAccademica
GIORNATA MONDIALE TUMORE DEL PANCREAS Il nostro contributo con un video su un percorso di cura a cui tutti i pazienti dovrebbero avere accesso: bit.ly/WPCD-23-CV Video realizzato con soli strumenti di AI @headlighty @AISP_Pancreas
That's the way ...
In @JCOCCI_ASCO Real-Time Identification of #PancreaticCancer Cases Using Artificial Intelligence Developed on Danish Nationwide Registry Data ascopubs.org/doi/abs/10.120… The machine learning algorithm used here was able to identify high risk groups with a 10.1% risk of being…
L'ambiente accademico è uno degli ambiti professionali più chiusi che si possa immaginare.
I wonder what postmortem @Penn is doing, given their past mistake: "UPenn told me that they’d had a meeting and concluded that I was not of faculty quality. When I told them I was leaving, they laughed at me and said, ‘BioNTech doesn’t even have a website.’"
Crowds gather to hear @EileenMOReilly @MSKCancerCenter talk on the immunological correlatives of @ElicioTx amphiphilic lymph node targeted vaccine directed against mutant KRAS in surgically resected #PancreaticCancer (and #ColorectalCancer) with ctDNA or CA19-9 positive minimal…
#AACRPan23 talk by Dr. Gulam Manji @columbiacancer on CheMoMETPANC 👉🏽 gemcitabine plus nab-paclitaxel + motixafortide (CXCR4 antagonist) + cemiplimib in advanced #PancreaticCancer. Responses observed in both primary & metastatic sites, with 64% partial responses & 27% stable…
#TumorBoardTuesday Thursday wrap up! @CentralParkWMD @ferguskeane2 led the discussion. More and more, molecular 🎯 different options in #PDAC. ✅HRD- PARPi; always want to go for curative surg if possible, but in met or 2L setting ✅KRAS- G12C small # of cases, G12D inhibs in…
The relapse rate is another uncharted territory in the article.
Word of caution on artery rsxn for PDAC: 1)These series reflect significant selection over decades where denominators not known. 2) Survival not clearly improved vs just chemo 3) high recurrence 4)high mortality and morbidity.@bjs @DrJashDatta academic.oup.com/bjs/article/11…
So true!!
“If we could change the diagnostic odyssey, we could actually change the power balance of patients in the health-care system” - @TaniaSimoncelli, VP Science in Society @cziscience
Grazie a Pieve _Skin, un'incredibile comunità di parenti e amici di Paolo Campanini tutti determinati a portare avanti le idee di Paolo. Grazie alla Regione Emilia Romagna, @RegioneER, per l'ascolto, l'ospitalità e l'impegno a migliorare le cure oncologiche
#Sanità. #Solidarietà, il gruppo “#PieveSkin” ha consegnato oggi in #RegioneER un assegno da 15mila euro in favore dell’associazione #CodiceViola, che da anni aiuta i malati di #tumore al #pancreas e le loro famiglie. La #notizia 👉 regioneer.it/SolidarietaPie…
Widespread issue
Last year, I was offered a job even after disclosing a stage IV cancer diagnosis. Highlighting the very best of workplace acceptance and culture. But today, my husband unexpectedly had a job offer rescinded after letting the company know he may need 2 days off, a month after…
VACCINI E TUMORE DEL PANCREAS Finalmente degli spiragli seri per delle potenziali opzioni di cura per una patologia per la quale da dieci anni non ci sono stati progressi terapeutici significativi
Vaccine boosts T cells that target pancreatic tumours. Read about this clinical trial in a super N&V by @AmandaHuffPhD & @NeehaZaidi go.nature.com/44Iao5b
Bella differenza rispetto a tanti presunti scienziati
"We are not making science for science. We are making science for the benefit of humanity." This #WorldHealthDay we celebrate Françoise Barré-Sinoussi, awarded the 2008 Nobel Prize in Physiology or Medicine for her role in the discovery of human immunodeficiency (HIV) virus.
!!
"We are not making science for science. We are making science for the benefit of humanity." This #WorldHealthDay we celebrate Françoise Barré-Sinoussi, awarded the 2008 Nobel Prize in Physiology or Medicine for her role in the discovery of human immunodeficiency (HIV) virus.
Regionalization of #PDAC treatment can improve outcomes, but barriers must be considered. Addressing the barriers is crucial for successful implementation of regionalization policies. (via Textbook of #PancreaticCancer @ksoreide) #QualityofCancerCare #neglectedcancers @my_ueg
Shedding light on a largely underestimated topic: #Cancer burden in #adolescents and young adults in Europe. Just published in @ESMO_Open by @myESMO esmoopen.com/article/S2059-…
TUMORE PANCREAS, OLAPARIB E AIFA Dopo la nostra intervista, la nota AIFA sulla non rimborsabilità del farmaco Olaparib, Michele Reni, oncologo di riferimento sul tumore pancreas, confuta @Aifa_ufficiale con dati clinicamente significativi bit.ly/Ol-AIFA-RE
Purtroppo questo non succede solo per il Ministro dell'Economia, la scarsa presenza in. Europa è un problema generalizzato che ci penalizza in modo significativo.
Italian Minister of Economy and Finance did not travel to Davos, I guess Intel future investments in Europe not of interest
United States Trends
- 1. Mike Rogers 149 B posts
- 2. #FridayVibes 7.658 posts
- 3. Good Friday 67,4 B posts
- 4. Muppets 3.993 posts
- 5. Pam Bondi 330 B posts
- 6. Jason Kelce 2.011 posts
- 7. Happy Friyay 2.831 posts
- 8. CONGRATULATIONS JIMIN 331 B posts
- 9. #BOYCOTT143ENT 11 B posts
- 10. #FursuitFriday 12,8 B posts
- 11. $MAD 5.749 posts
- 12. #FridayMotivation 12,4 B posts
- 13. #WeStandWithMadein 9.675 posts
- 14. Roller Coaster 3.498 posts
- 15. McCabe 27,2 B posts
- 16. Chris Brown 32,5 B posts
- 17. Randle 7.731 posts
- 18. Dan Scavino 2.141 posts
- 19. Kang 36,8 B posts
- 20. Jim Cramer 2.197 posts
Who to follow
-
Pancreatic Cancer Europe (PCE)
@P_C_E_ -
AISP
@AISP_Pancreas -
Stefano Crippa
@StefanoCrippa6 -
Roberto Valente
@RobValente83 -
W P C C
@worldpcc -
Nine de Graaf
@nine_degraaf -
Salvatore Paiella
@Totuccio1983 -
Marta Chiaravalli
@martachrvll -
Fondazione Nadia Valsecchi Onlus
@Valsecchifdn -
Arghavan Salles, MD, PhD
@arghavan_salles -
Cancer Care Parcel
@CancerParcel -
HBPSurG
@hbpsurg_eu -
Stefano Partelli
@spartelli -
Alberto Balduzzi
@albe_balduzzi -
PrecisionPanc
@precisionpanc
Something went wrong.
Something went wrong.